tradingkey.logo

Intelligent Bio Solutions Inc

INBS
6.140USD
-0.850-12.16%
收盘 12/19, 16:00美东报价延迟15分钟
55.86M总市值
亏损市盈率 TTM

Intelligent Bio Solutions Inc

6.140
-0.850-12.16%

关于 Intelligent Bio Solutions Inc 公司

Intelligent Bio Solutions Inc. is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its segment includes Commercially available Intelligent Fingerprinting Products and Development Stage Biosensor Platform Technology. Its product portfolio includes Intelligent Fingerprinting Platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader, and a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Biosensor Platform is designed to detect multiple biological analytes by substituting the top enzyme layer of the biosensor to suit each analyte and to develop a range of Point of Care Tests, including the modalities of clinical chemistry, immunology, tumor markers, allergens, and endocrinology.

Intelligent Bio Solutions Inc简介

公司代码INBS
公司名称Intelligent Bio Solutions Inc
上市日期Dec 23, 2020
CEOSimeonidis (Harry)
员工数量16
证券类型Ordinary Share
年结日Dec 23
公司地址135 W 41St St,
城市NEW YORK
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编10036
电话16467905756
网址https://ibs.inc/
公司代码INBS
上市日期Dec 23, 2020
CEOSimeonidis (Harry)

Intelligent Bio Solutions Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--
Mr. Jason Isenberg
Mr. Jason Isenberg
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Harry Simeonidis
Mr. Harry Simeonidis
President, Chief Executive Officer
President, Chief Executive Officer
40.41K
--
Mr. Jonathan S. Hurd
Mr. Jonathan S. Hurd
Independent Director
Independent Director
63.00
--
Mr. Valter Pinto
Mr. Valter Pinto
Managing Director
Managing Director
--
--
Dr. Steven Boyages, Ph.D.
Dr. Steven Boyages, Ph.D.
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Spiro Sakiris
Mr. Spiro Sakiris
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Nicola Fraser
Ms. Nicola Fraser
Independent Director
Independent Director
--
--

收入明细

单位: USD更新时间: 10月6日 周一
单位: USD更新时间: 10月6日 周一
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United Kingdom
2.87M
93.96%
Rest of world
132.70K
4.35%
Australia
29.17K
0.96%
Americas
22.64K
0.74%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月15日 周六
更新时间: 11月15日 周六
持股股东
股东类型
持股股东
持股股东
占比
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
其他
86.34%
持股股东
持股股东
占比
Alyeska Investment Group, L.P.
7.02%
Adar1 Capital Management LLC
4.44%
The Vanguard Group, Inc.
1.02%
Geode Capital Management, L.L.C.
0.61%
Sakiris (Spiro Kevin)
0.56%
其他
86.34%
股东类型
持股股东
占比
Hedge Fund
11.51%
Investment Advisor
1.33%
Individual Investor
0.99%
Investment Advisor/Hedge Fund
0.61%
Research Firm
0.14%
其他
85.42%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
31
799.23K
8.80%
-446.50K
2025Q2
34
836.82K
11.26%
+144.79K
2025Q1
36
981.28K
14.20%
+429.65K
2024Q4
38
214.35K
3.16%
-507.92K
2024Q3
38
390.00K
7.80%
-236.97K
2024Q2
42
449.42K
76.55%
-259.12K
2024Q1
46
732.30K
88.07%
+589.21K
2023Q4
40
172.56K
98.30%
+79.74K
2023Q3
42
49.64K
11.24%
+14.21K
2023Q2
43
60.27K
19.45%
+30.17K
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Alyeska Investment Group, L.P.
613.89K
6.76%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
15.48K
0.17%
--
--
Jun 30, 2025
Geode Capital Management, L.L.C.
51.45K
0.57%
+2.44K
+4.98%
Jun 30, 2025
Sakiris (Spiro Kevin)
53.93K
0.59%
--
--
Sep 11, 2025
Simeonidis (Harry)
40.41K
0.45%
--
--
Sep 11, 2025
Goldman Sachs & Company, Inc.
12.83K
0.14%
+10.00
+0.08%
Jun 30, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
公告日期
类型
比率
Dec 12, 2025
Merger
10→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Jan 25, 2024
Merger
12→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1
Feb 09, 2023
Merger
20→1

常见问题

Intelligent Bio Solutions Inc的前五大股东是谁?

Intelligent Bio Solutions Inc 的前五大股东如下:
Alyeska Investment Group, L.P.持有股份:613.89K,占总股份比例:6.76%。
The Vanguard Group, Inc.持有股份:15.48K,占总股份比例:0.17%。
Geode Capital Management, L.L.C.持有股份:51.45K,占总股份比例:0.57%。
Sakiris (Spiro Kevin)持有股份:53.93K,占总股份比例:0.59%。
Simeonidis (Harry)持有股份:40.41K,占总股份比例:0.45%。

Intelligent Bio Solutions Inc的前三大股东类型是什么?

Intelligent Bio Solutions Inc 的前三大股东类型分别是:
Alyeska Investment Group, L.P.
Adar1 Capital Management LLC
The Vanguard Group, Inc.

有多少机构持有Intelligent Bio Solutions Inc(INBS)的股份?

截至2025Q3,共有31家机构持有Intelligent Bio Solutions Inc的股份,合计持有的股份价值约为799.23K,占公司总股份的8.80%。与2025Q2相比,机构持股有所增加,增幅为-2.45%。

哪个业务部门对Intelligent Bio Solutions Inc的收入贡献最大?

在FY2025,--业务部门对Intelligent Bio Solutions Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI